Skip to main content
. 2024 Mar 13;67(7):1529–1538. doi: 10.1007/s10840-024-01786-y

Table 3.

Complications and adverse events

Complications, n (%) PVI (n = 59) CTI ablation (n = 54) P-value
Composite safety endpoint 5 (8.5) 6 (11.1) 0.755
Groin haematoma 2 (3.4) 0.497
All-cause hospitalisation* 18 (30.5) 12 (22.2) 0.395
Pericarditis
Pericardial effusion 1 (1.7)  > 0.999
Phrenic nerve palsy
Requirement for pacemaker 1 (1.7) 5 (9.3) 0.102
Stroke or TIA
Myocardial infarction 1 (1.7)  > 0.999
Atrio-oesophageal fistula
All-cause death 3 (5.1) 1 (1.9) 0.620

CTI cavotricuspid isthmus ablation, PVI pulmonary vein isolation, TIA transient ischaemic attack

*All-cause hospitalisation is described here as a binary outcome, i.e., a patient either had a hospitalisation during follow-up or did not. Further details about all-cause hospitalisation is given in the text